Improved gene expression pattern using Epstein-Barr virus (EBV)-based plasmid and cationic emulsion

Biomaterials

Volumn 26, Issue 9, 2005, Pages 1063-1070

  Min, Kyoung Ah ^a   Lee, Suk Kyeong ^b   Kim, Chong Kook ^a  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Emulsion; Episomal plasmid; Epstein Barr virus; Gene expression

Indexed keywords

CATIONIC EMULSIONS; EPSTEIN-BARR VIRUS (EBV); TRANSFECTION EFFICIENCY;

ANTIGENS; CELLS; DNA; PARTICLE SIZE ANALYSIS; POSITIVE IONS; PROTEINS; VIRUSES;

GENES;

3 N (N',N' DIMETHYLAMINOETHANE)CARBAMOYLCHOLESTEROL; CASTOR OIL; CATION; CELL NUCLEUS ANTIGEN; CHOLESTEROL DERIVATIVE; DEOXYRIBONUCLEASE I; DNA; EMULSIFYING AGENT; GREEN FLUORESCENT PROTEIN; LIPOFECTIN; PLASMID VECTOR; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ARTICLE; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; DNA DRUG COMPLEX; DNA REPLICATION ORIGIN; DRUG STABILITY; EMULSION; EPSTEIN BARR VIRUS; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; REPORTER GENE; TRANSGENE; ZETA POTENTIAL;

CARCINOMA, HEPATOCELLULAR; CASTOR OIL; CATIONS; CELL LINE, TUMOR; CHOLESTEROL; DNA, VIRAL; DRUG DELIVERY SYSTEMS; EMULSIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; LIVER NEOPLASMS; TRANSFECTION;

CASTOR; HUMAN HERPESVIRUS 4;

EID: 4444313274     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.04.005     Document Type: Article

References (30)

1. Benns J.M., Kim S.W. Tailoring new gene delivery designs for specific targets. J Drug Target. 8:2000;1-12
2. Nabel G.J. Development of optimized vectors for gene therapy. Proc Natl Acad Sci USA. 96:1999;324-326
3. Peng K.W., Vile R. Vector development for cancer gene therapy. Tumor Target. 4:1999;3-11
4. Rolland A.R. From genes to gene medicine. recent advances in nonviral gene delivery Crit Rev Ther Drug Carrier Syst. 15:1998;143-198
5. Crystal R.G. Transfer of genes to humans. early lessons and obstacles to success Science. 270:1995;404-410
6. Wilson J.M. Adenoviruses as gene-delivery vehicles. Mol Med. 18:1996;1185-1187
7. Gao X., Huang L. Cationic liposomes-mediated gene transfer. Gene Ther. 2:1995;710-722
8. Zabner J. Cationic lipids used in gene transfer. Adv Drug Deliv Rev. 27:1997;17-28
9. Sternberg B., Sorgi F.L., Huang L. New structures in complex formation between DNA and cationic liposomes visualized by freeze fracture electron microscopy. FEBS Lett. 356:1994;361-366
10. Zelphati O., Nguyen C., Ferrari M., Felgner J., Tsai Y., Felgner P.L. Stable and monodisperse lipoplex formulations for gene delivery. Gene Ther. 5:1998;1272-1282
11. Hong K., Zheng W., Baker A., Papahadjopoulos D. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. 400:1997;233-237
12. Singhi M., Ravin L.J. Parenteral emulsions as drug carrier systems. J Parenter Sci Technol. 40:1986;34-41
13. Benita S., Levy M.Y. Submicron emulsions as colloidal drug carriers for intravenous administration. comprehensive physicochemical characterization J Pharm Sci. 82:1993;1069-1079
14. Liu F., Yang J.P., Huang L., Liu D. Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer. Pharm Res. 13:1996;1642-1646
15. Yi S.W., Yune T.Y., Kim T.W., Chung H., Choi Y.W., Kwon I.C., Lee E.B., Jeong S.Y. A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system. Pharm Res. 17:2000;314-320
16. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields B.N., Knipe D.M., Howley P.M. Fields virology. 3rd ed:1996;2397-2446 Lippincott Williams & Wilkins, Philadelphia
17. Yates J.L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 313:1985;812-815
18. Yates J.L., Guan N. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol. 65:1991;483-488
19. Min K.A., Oh S.T., Yoon K.H., Kim C.K., Lee S.K. Prolonged gene expression in primary porcine pancreatic cells using an Epstein-Barr virus-based episomal vector. Biochem Biophys Res Commun. 305:2003;108-115
20. Choi WJ, Kim JK, Choi SH, Park JS, Ahn WS, Kim CK. Low toxicity of cationic lipid-based emulsion for gene transfer. Biomaterials 2004, in press.
21. Kim C.K., Haider Kh.H., Choi S.H., Choi E.J., Ahn W.S., Kim Y.B. Nonviral vector for efficient gene transfer to human ovarian adenocarcinoma cells. Gynecol Oncol. 84:2002;85-93
22. Thierry A.R., Rabinovich P., Peng B., Mahan L.C., Bryant J.L., Gallo R.C. Characterization of liposome-mediated gene delivery. expression, stability and pharmacokinetics of plasmid DNA Gene Ther. 4:1997;226-237
23. Ajmani P.S., Hughes J.A. 3Beta [N-(N′,N′-dimethylaminoethane) -carbamoyl] cholesterol (DC-Chol)-mediated gene delivery to primary rat neurons. characterization and mechanism Neurochem Res. 24:1999;699-703
24. Singh M., Kisoon N., Ariatti M. Receptor-mediated gene delivery to HepG2 cells by ternary assemblies containing cationic liposomes and cationized asialoorosomucoid. Drug Deliv. 8:2001;29-34
25. Mahato R.L., Rolland A., Tomlinson E. Cationic lipid-based gene delivery systems. pharmaceutical perspectives Pharm Res. 14:1997;853-859
26. Kim T.W., Chung H., Kwon I.C., Sung H.C., Jeong S.Y. Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents. Pharm Res. 18:2001;54-60
27. Zabner J., Fasbender A.J., Moninger T., Poellinger K.A., Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem. 270:1995;18997-19007
28. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Nothrop J.P., Ringold G.M., Danielsen M. Lipofection. a highly efficient, lipid-mediated DNA transfection procedure Proc Natl Acad Sci USA. 84:1987;7413-7417
29. Jankelevich S., Kolman J.L., Bodnar J.W., Miller G. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J. 11:1992;1165-1176
30. Middleton T., Sugden B. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein (EBNA-1). J Virol. 68:1994;4067-4071